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Corres ndence
Environmental Estrogens
The estrogenic equivalent analysis that Dr.
Safe presented recently in EHP (103:346-
351) is a welcome addition to the litera-
ture, and development of this toxicologic
approach is an important step in evaluating
new endpoints for environmental agents
(1,2). The hormonal potential ofchemical
contaminants offers many opportunities
for further research, including study ofthe
environmental etiology ofbreast cancer.
Complex mixtures are of great impor-
tance for human environmental exposures,
but we understand neither exposure nor
effect very well. Safe, as a basis for evaluat-
ing one hormonal endpoint, offers estro-
genic equivalents acting in an additive
fashion. In future research, we need to
learn whether these combinations ofchem-
icals, such as DDT and estrogen, may be
additive or multiplicative. Examples of
both exist. Thus, in vitro assays using
MCF7 breast tumor cells found an addi-
tive effect for 10 pesticides (3), and in vivo
assays of two PCB metabolites produced
an apparent multiplicative effect in altering
gender determination in turtles (4).
We also need to investigate hormonally
active compounds for other relevant bio-
logical activity. For example, vinclozilin
has androgenic potential (5); genistein may
act as a free radical scavenger (6); andpp'-
DDE demonstrated potent anti-andro-
genic responses in the rat (8). Estrogenicity
ofgenistein and other phytoestrogens may
be relevant to breast cancer, but countries
with high dietary intake of such com-
pounds are generally at low risk for breast
cancer. Therefore, it is possible that exoge-
nously derived phytoestrogens act differ-
ently from steroid hormones, perhaps by
altering levels offree versus bound estrogen
or by increasing estrogen excretion through
the biliary/fecal route (8).
It has become more and more apparent
that toxicokinetics ofchemicals is a critical
component ofdose-response relationships.
Endogenous levels of organochlorines in
women today are 10-fold higher than those
of estrogen (9), and their effects are pro-
longed because of their persistence in the
body. Toxicokinetics are also closely tied
to PCB toxicity (1(1); thus 2,2',5,5'-tetra-
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chlorobiphenyl, an estrogenic compound,
is short-lived in the body compared to
2,2',4,4',5,5'-hexachlorobiphenyl. The
latter has little estrogenic behavior in rats
until 20 or more days after exposure (11).
In addition, PCBs may also have potent
antiestrogenic behavior (e.g., 3,3',4,4'-
tetrachlorobiphenyl). Humans and wildlife
have been exposed to mixtures of PCBs
that possess a range of estrogenic activity,
and the interaction of various PCB con-
geners has not been widely studied. PCBs
may be synergistic, as in the example cited
above (4), but their hormonal activity can
also differ in different experiments, as with
Aroclor 1254 (12,13). Indeed, the ability
of chemicals in the body to act both as
agonists and antagonists is well known; for
example, soy products and tamoxifen can
be both estrogenic and antiestrogenic.
These contrasting endpoints can be attrib-
uted to different mechanism as well as to
pharmacokinetics.
As Safe notes, pp'-DDE is the pre-
dominant (>90%) residue of DDT in the
environment. While DDT may be unde-
tectable in some assay conditions, pp'-
DDT is still routinely found in women,
albeit at low levels. Other isomers includ-
ing o,p'-DDT may be currently unde-
tectable, but they may have been present at
an earlier time, so that measurement of
DDE alone can serve as a surrogate for
prior exposures to other isomers. More-
over, with respect to breast cancer, the
effect of organochlorines may arise from
mechanisms not directly involving the
estrogen receptor, such as induction of
P450 enzymes.
I agree with Safe that the current evi-
dence is far from conclusive about the asso-
ciation of organochlorine exposure and
breast cancer risk, and the many confirma-
tory studies now underway will improve
our knowledge in this regard. The connec-
tion to male reproduction, including
sperm counts, is highly speculative.
However, the existing data, along with
ample evidence ofendocrine disruption in
wildlife, provide a clear challenge for basic
and epidemiologic researchers to uncover
public health risks arising from environ-
mental exposures.
Mary S. Wolff
Mt. Sinai School ofMedicine
NewYork, NewYork
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Response
In her letter, Dr. Wolffcorrectly points out
the difficulties in assessing the potential
adverse impacts of chemical mixtures con-
taining compounds which exhibit both
common (e.g., estrogenic) and diverse
activities. Despite these problems, it is not
unreasonable or unprecedented to deter-
mine levels and relative potencies of indi-
vidual compounds in a mixture which elicit
common responses and/or act through sim-
ilar pathways. This method is the toxic
equivalency factor (TEF) approach for haz-
ard assessment ofchemical mixtures, which
bydefinition focuses only on specific chem-
ical-induced responses. Regulatory agencies
use a TEF approach for hazard assessment
of 2,3,7,8,-tetrachlorodibenzo-p-dioxin
(TCDD) and related compounds (1) and
estrogen equivalents have previously been
used for determining human exposure to
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